The Long Shadow of Early HCMV–HIV Coinfection: Epidemiology, Pathogenesis, and Immune Consequences
Children · 07.02.2026 · 13 (2) · 236
DOI: 10.3390/children13020236 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Children, online erschienen am 07.02.2026. Verfasst von Camilla Albano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Pediatric Sciences, Medical School, University of Turin, 10124 Turin, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research—MUR, ESCMID Research Grant.
Abstract (Originalsprache)
Human cytomegalovirus (HCMV) and Human Immunodeficiency Virus (HIV) are two pathogens known to have dramatic consequences when contracted early in life. In addition to having a significant impact when acquired individually, these two viruses are known to frequently cause coinfections. Indeed, also in the modern era, HCMV remains one of the most prevalent coinfections in newborns of mothers living with HIV, including both HIV-positive children regardless of their immune status, and those exposed to HIV but uninfected (HEU). In children with HIV infection, HCMV coinfection has historically been associated with AIDS-defining disease, high mortality, and prolonged, elevated HCMV viral load. Although timely administration of antiretroviral therapy prevents immunodeficiency in people living with HIV and thus reduces the incidence of full-blown HCMV disease in cases of coinfection, emerging data suggest that HCMV-induced immune activation and aging persist, potentially contributing to long-term, non-AIDS-related comorbidities. Growing evidence indicates that also HCMV amplifies HIV susceptibility, disease progression, and immune dysregulation through multiple synergistic mechanisms. Moreover, congenital and early postnatal HCMV infections occur at significantly higher rates in HEU newborns than in HIV-unexposed children and are associated with worse clinical outcomes, particularly when HCMV viral loads are high. This review summarizes current knowledge on the epidemiology, clinical impact, and immunopathogenetic interactions of early HCMV–HIV coinfection in pediatric populations. By integrating recent findings with historical evidence, it highlights critical mechanistic and epidemiological gaps that warrant further investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health and Pediatric Sciences, Medical School, University of Turin, 10124 Turin, Italy.
ORCID-Profile: Camilla Albano, Francesca Gugliesi, Greta Bajetto, Beatrice Braga, Valentina Dell'Oste, Gloria Griffante, Selina Pasquero
Förderung
- Italian Ministry of University and Research—MUR
- ESCMID Research Grant
Zitieren
APA
Albano, C., Gugliesi, F., Bajetto, G., Braga, B., Dell'Oste, V., Griffante, G., & Pasquero, S. (2026). The Long Shadow of Early HCMV–HIV Coinfection: Epidemiology, Pathogenesis, and Immune Consequences. Children, 13(2), 236. https://doi.org/10.3390/children13020236
Vancouver
Albano C, Gugliesi F, Bajetto G, Braga B, Dell'Oste V, Griffante G, et al. The Long Shadow of Early HCMV–HIV Coinfection: Epidemiology, Pathogenesis, and Immune Consequences. Children. 2026;13(2):236. doi:10.3390/children13020236
BibTeX
@article{Albano2026,
author = {Albano, Camilla and Gugliesi, Francesca and Bajetto, Greta and Braga, Beatrice and Dell'Oste, Valentina and Griffante, Gloria and Pasquero, Selina},
title = {The Long Shadow of Early HCMV–HIV Coinfection: Epidemiology, Pathogenesis, and Immune Consequences},
journal = {Children},
year = {2026},
volume = {13},
number = {2},
pages = {236},
doi = {10.3390/children13020236}
}
EUVIMED